Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California.
Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 a.m. Nov. 6.
CEO Frank Oakes and other employees from Stellar Biotechnologies rang the closing bell after common shares of Stellar started trading on the exchange. Common shares of Stellar Biotechnologies are also traded on Canada’s TSX Venture Exchange.
• Contact Philip Joens at [email protected]